Novakand Pharma AB (KAN.ST) Q2 2024 Earnings

17MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.12
0.22
0.55
0.88

Details

Expected EPS
-0.115580585583936
Actual EPS
N/A
Surprise EPS
0.12
Surprise Percent
+100%

Description

Novakand Pharma AB (KAN.ST) will report earnings of for Q2 2024 on May 17, 2024.

0 Comments

Share your thoughts